The Feasibility of Selectively Omission of Radiation to Level IB Lymph Nodes in Low-Risk Nasopharyngeal Carcinoma

X. Ou,Y. Miao,C. Hu

DOI: https://doi.org/10.1016/j.ijrobp.2017.06.581

2017-01-01

Abstract:Level IB metastasis is relatively rare in nasopharyngeal carcinoma (NPC). However, many institutions recommend electively irradiation to level IB to level V in NPC, which covers the submandibular glands (SMG) in the target volume and is associated with deterioration of xerostomia. The purpose of this study is to investigate the high-risk factors for level IB metastasis in NPC and evaluate the feasibility of selectively omission of radiation to level IB in the low-risk subgroups. This retrospective study identified 532 patients with non-metastatic NPC treated by intensity modulated radiation therapy (IMRT) in our institution from 2009 to 2010. Level IB nodes were electively included in the clinical target volume based on the attending physician’s decision. At that time, the SMG dose was not constrained during inverse treatment planning. Late xerostomia was scored according to CTCAE 3.0 system. Diagnostic head and neck MRIs were retrospectively reviewed and the involvement of nodal levels was evaluated according to RTOG guidelines. The correlation of level IB metastasis and other imaging factors were studied using Chi-square test and logistic regression model. Log-rank test was used to compare survival rates. Cox proportional-hazards models were used to evaluate the effect of various factors on survival. Univariate analysis showed that advanced N stage, bilateral nodal metastasis, level IIA involvement, the maximal axial diameter (MAD) of level IIA nodes >20 mm, necrosis or extracapsular spread of level IIA correlated with level IB metastasis at diagnosis. In multivariate analysis (MVA), bilateral nodal involvement, MAD of level IIA nodes >20 mm or extracapsular spread of level IIA nodes, were independent predictive factors of level IB metastasis at diagnosis. Patients without either of these factors were denoted low-risk subgroup and the rest high-risk subgroup. With a median follow-up of 51.5 (1.0-74.7) months, the 5-year estimated regional control and overall survival (OS) was 94.4% and 84.8%, respectively. Of the low-risk subgroup, there was no significant difference of regional control and OS between those with or without elective irradiation to level IB. The percentage of level IB recurrence of those without elective irradiation was only 0.46%. Elective level IB irradiation was not significant upon MVA both for regional control and OS. Of the high-risk subgroup, elective level IB irradiation was marginal significant for regional control, but not for OS upon MVA. Overall, elective irradiation of level IB increased the mean doses of SMGs, but did not transfer into reduction of late xerostomia. Our study demonstrated the MAD of level IIA nodes > 20 mm and/or level IIA nodes with extracapsular spread, positive bilateral cervical lymph nodes were independent risk factor for level IB metastasis in NPC. For patients without either of these factors, selectively omission of irradiation to level IB did not impair regional control and OS.